File:CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals -Figure 3.png

From Wikisource
Jump to navigation Jump to search
Description

CCL3L1-CCR5 GRGs influence median time-from-seroconversion to CD4 cell count thresholds that might be used to guide initiation of HAART, and time from a high to a low CD4 cell count.

In Panel A, KM plots show the time-from-seroconversion to arrival at <450 (left), <350 (center) or <200 (right) CD-cells/mm3. In Panel B, the KM plots are for progression from <450 to <200 CD4-cells/mm3 in all seroconverters (left) or seroconverters recruited and followed during the years 1990 to 1999, a time-period in which antiretroviral therapy was available (right). The color codes for the KM plots in panel B are: blue, low GRG; brown, moderate and high GRGs combined into a single category; and black, all subjects. Overall P values are at the top of each plot. Color-coded numbers at the upper right of the KM plots represent the median time-to-event, that is, from seroconversion to the indicated CD4 cell count. In panel A, P values for differences in median time-to-event relative to those with a low GRG were: *, 0.1131; †, 0.0089; ‡, 0.0030; §, 0.0005; ¶, 0.0001; and ∥, 9.6×10−7. RH, relative hazard; CI, confidence interval. P values in Panel B are adjusted for the steady-state viral load, baseline CD4 and best DTH response recorded during disease course, and subjects with a moderate or high GRG were combined into a single category.

Uploaded for use in s: CCL3L1-CCR5 Genotype Improves the Assessment of AIDS Risk in HIV-1-Infected Individuals
Date Sept 08
Source http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0003165
Author Hemant Kulkarni, Brian K. Agan, Vincent C. Marconi, Robert J. O'Connell, Jose F. Camargo, Weijing He, Judith Delmar, Kenneth R. Phelps, George Crawford, Robert A. Clark, Matthew J. Dolan, Sunil K. Ahuja
Permission
(Reusing this file)
This is an open-access article distributed under the terms of the Creative Commons Public Domain declaration which stipulates that, once placed in the public domain, this work may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose.
Creative Commons Public domain This file has been released explicitly into the public domain by its author, using the Creative Commons Public Domain Dedication formerly here

This file may be used for any purpose including unrestricted redistribution, commercial use, and modification.


Note: Creative Commons has retired this legal tool and does not recommend that it be applied to works. It is recommended you use {{Cc-zero}} instead.
This legal tool may not be effective or applicable in non-US jurisdictions.

Captions

Add a one-line explanation of what this file represents

Items portrayed in this file

depicts

image/png

799c84534b5865fdae7a19a99d5ca81c180dc399

158,520 byte

600 pixel

566 pixel

File history

Click on a date/time to view the file as it appeared at that time.

Date/TimeThumbnailDimensionsUserComment
current11:01, 14 September 2008Thumbnail for version as of 11:01, 14 September 2008566 × 600 (155 KB)Anonymous101{{Information |Description= CCL3L1-CCR5 GRGs influence median time-from-seroconversion to CD4 cell count thresholds that might be used to guide initiation of HAART, and time from a high to a low CD4 cell count. In Panel A, KM plots show the time-from-ser